How the DEA’s Attempt to Reschedule Kratom Could Endanger Public Health and Addiction Treatment

When the DEA announced their sudden decision to classify kratom as a Schedule 1 substance earlier this summer, people went into an uproar. Practitioners, scientists, and even politicians threw their weight into the fight to delay the emergency rescheduling of the plant many use to treat addiction. Some of the backlash—a letter to the DEA […]

Continue Reading

Dr. Deborah Mash on Why Ibogaine Treatment Aftercare is Key to Treating the Roots of Addiction

When Dr. Deborah Mash met the grandfather of ibogaine treatment, Howard Lotsof, and observed first-hand the effectiveness that ibogaine had for addiction interruption, she knew she’d found something special. Within a relatively short period of time, she petitioned for and received FDA approval to begin studying ibogaine within the US but soon ran into funding […]

Continue Reading